RA Capital Nexus Fund III, Director: Bicara Therapeutics BCAX Buy · Filed 24/09/18

Trade details

Type: Insider buy
Amount: $30,249,360
Shares · price: 1,680,520 sh · $18.00 a share
Held after: 4,303,418 sh
Stock: Bicara Therapeutics BCAX
Person: RA Capital Nexus Fund IIIDirector
Trade date: 24/09/16
Filed: 24/09/18
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 11 insiders
Holding change: +64.1%

Bicara Therapeutics trades, last 26 weeks

What else happened in Bicara Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/17~24/10/16

RA Capital Nexus Fund III's recent trades

RA Capital Nexus Fund IIIDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$3.4M
391,019 sh
$3.4M
Filed 06/16
Traded 06/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$1.1M
124,893 sh
$1.1M
Filed 06/16
Traded 06/16

RA Capital Nexus Fund III, Director — bought $30.2M of Bicara Therapeutics BCAX · 1,680,520 sh @ $18.00 | Whalegun